Showing 91-100 of 9540 results for "".
Why Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.Optimizing Approaches to Rejuvenation
https://practicaldermatology.com/topics/practice-management/optimizing-approaches-to-rejuvenation/21036/Insights from DermTube.com about the latest approaches to cosmetic dermatology.Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.Pipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigMeaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivDermoscopy Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermoscopy-pearls/19985/Steven Q. Wang discusses some of the challenges of managing patients with melanoma, the importance of early diagnosis without performing too many biopsies, and the pitfalls of specific lesions, including featureless, small, and collision lesions.Embracing AI
https://practicaldermatology.com/topics/practice-management/embracing-ai/20080/Artificial intelligence is something dermatologists should be embracing as augmented intelligence. Anthony Rossi, MD says this intelligence will allow us to better diagnose, assess, and treat patients with everything from acne to melanoma.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Clinical Focus: Acne: Back in the Spotlight: Effective Options for Truncal Acne
https://practicaldermatology.com/topics/general-topics/back-in-the-spotlight-effective-options-for-truncal-acne/22031/Data suggest that patients may be unlikely to report truncal acne. Clinicians must assess chest and back involvement and be prepared to offer effective treatments.Acne Management Today: Exploring the Role of Topical Adapalene in OTC Care
https://practicaldermatology.com/topics/acne-rosacea/acne-management-today-exploring-the-role-of-topical-adapalene-in-otc-care/23205/La Roche-Posay’s EFFACLAR Adapalene 0.1% Gel provides effective OTC care for acne.